Bartha Maria Knoppers

This book is the first systematic, detailed treatment of the approaches to ethical issues taken by biotech and pharmaceutical companies. The application of genetic/genomic technologies raises a whole spectrum of ethical questions affecting global health that must be addressed. Topics covered in this comprehensive survey include considerations for bioprospecting in transgenics, genomics, drug discovery, and nutrigenomics, as well as how to improve stakeholder relations, design ethical clinical trials, avoid conflicts of interest, and establish ethics advisory boards. The expert authors represent multiple disciplines including law, medicine, bioinformatics, pharmaceutics, business, and ethics.

This book is the first analysis of the law in Canada pertaining to the health of children. It reflects the collaborative effort and concern of four national centres - Centre de recherch en droit public; Canadian Research Institute for Law and the Family; Canadian Institute of Child Health; and the Canadian Human Rights Foundation. The book begins with a factual picture of the health of Canadian children - the causes of disability, injury and death, the types of programs and policies in place and the success of such programs. It then examines the impact of public international law as it applies to the right to health generally and the implications of its interpretation for the right to health under the Convention and under current Canadian constitutional and criminal law. The possible recourse to the Convention for a positive or restrictive interpretation of this right under the common law of Canada or the civil law of Quebec are the focus of separate chapters. The final chapter is a discussion of the difficult question of research involving children.